Chris Price is the Founder of Red Fox Multifamily, LLC and a seasoned entrepreneur who has helped passive investors participate in over 1,200+ commercial multifamily units across strategic U.S. markets. His unique background bridges two worlds that rarely intersect—corporate pharmaceutical leadership and institutional real estate investing.
He has spent more than two decades in the life sciences industry as a corporate leader and director, launching brands, managing cross-functional teams, and navigating the complex regulatory and competitive landscape that defines modern pharmaceutical commerce. This experience gave him firsthand insight into the financial challenges facing high-income healthcare professionals: heavy concentration in employer stock, limited diversification options, and precious little time to research alternative investments.
He created Red Fox Multifamily specifically to give his peers in pharma a practical, thoroughly vetted way to invest beyond company stock plans, traditional retirement accounts, and volatile public markets—providing access to the same institutional-quality real estate that typically requires millions in capital or decades of industry experience.
Red Fox Multifamily sources private investment opportunities in commercial multifamily real estate alongside experienced, institutional-grade operating partners with proven track records in acquisition, renovation, and asset management.
We focus on 100+ unit apartment properties in markets demonstrating strong population growth, employment diversity, and favorable landlord-tenant regulations. These larger properties benefit from economies of scale and professional third-party management.
Our target markets include landlord-friendly states with robust employment across multiple sectors—including healthcare, biotechnology, technology, and professional services—reducing concentration risk and supporting consistent rental demand regardless of economic cycles.
Private syndications and funds often provide significant depreciation benefits that can offset passive income from real estate investments. In some cases, depending on an investor’s tax status and participation level, these losses may offer additional advantages. Individual tax situations vary considerably, so we recommend consulting your CPA or tax advisor to understand how these benefits apply to you and whether a cost segregation study may enhance your tax position.
We invest our own capital alongside our investor partners in every opportunity we present. Additionally, we only work with operators who meet our rigorous standards for experience, integrity, transparency, and alignment of interests through meaningful personal investment.
*All investments involve risk, are illiquid, and may result in loss of principal. This information does not constitute investment, legal, or tax advice. Consult your own financial, legal, and tax advisors before making any investment decisions.*
Our investor community consists of accomplished pharmaceutical and life sciences professionals who value education, transparency, and long-term strategic thinking over short-term speculation or get-rich-quick schemes.
You meet SEC accredited investor requirements—typically $200,000+ annual income (or $300,000 joint) or $1,000,000+ net worth excluding primary residence. Our investments are private placements available exclusively to accredited investors.
You work in pharmaceutical sales, medical affairs, clinical development, regulatory affairs, marketing, commercial operations, information technology, or life sciences leadership—and understand the unique financial situation of high-income healthcare professionals.
You recognize the risk of over-concentration in your employer's stock, equity compensation plans, and traditional retirement accounts—and want exposure to a different asset class with distinct return drivers and risk characteristics.
You value education over sales pressure, transparency over hype, and long-term wealth building over short-term speculation. You prefer hands-off investing that doesn't create compliance concerns or require active management time.
Before considering any investment, we believe you should thoroughly understand the fundamentals, risks, timelines, and tax implications of passive multifamily real estate investing. That's why we created a comprehensive educational experience specifically for pharmaceutical and life sciences professionals.
Our free educational webinar covers everything you need to know to make informed decisions about passive multifamily investing:
- The fundamental differences between passive multifamily syndications and being a direct landlord—and why busy professionals overwhelmingly prefer the former
- How high-income pharmaceutical professionals strategically use private real estate alongside traditional investments to reduce portfolio volatility and increase diversification
- Key performance metrics including cash-on-cash return, internal rate of return, equity multiple, and preferred returns—demystified in plain language
- Realistic timelines, hold periods, liquidity considerations, and exit strategies you should expect from private real estate investments
- Risk factors, market considerations, and important questions to ask before committing capital to any opportunity
- Tax advantages including depreciation, cost segregation, and strategies for optimizing after-tax returns
The webinar runs approximately 45 minutes and is available on-demand, so you can watch at your convenience—whether that's during your morning commute, lunch break, or evening at home.
Joining the Red Fox Investor Club is the first step toward diversifying your investment portfolio with institutional-quality multifamily real estate. Here's what you can expect after submitting your application:
We'll review your investor profile and accreditation status, typically within 2-3 business days. This ensures we're serving investors who align with our investment strategy and regulatory requirements.
Once approved, we'll schedule a brief introductory conversation to learn about your investment goals, answer your questions, and explain how our investment process works in detail.
You'll gain access to our private investor portal where you can review detailed investment opportunities, educational content, market research, and performance updates from existing investments.
As a member of our investor community, you'll receive regular market insights, quarterly performance reports, and invitations to live Q&A sessions with operating partners and industry experts.
- Priority access to new institutional quality investment opportunities before public marketing
- Detailed investment memorandums with comprehensive market and property analysis
- Direct access to experienced operating partners during due diligence
- Quarterly performance reporting and transparent communication
- Ongoing education about multifamily investing and wealth-building strategies
- Community of like-minded pharmaceutical professionals pursuing financial independence
Turn your active pharma income into diversified, tax-efficient passive income through professionally managed multifamily real estate.